Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation

European Journal of Pharmacology

Volumn 311, Issue 2-3, 1996, Pages 221-231

  Mousa, Shaaban A ^a,b   Schäfer, Michael ^a,b   Mitchell, W Mark ^a   Hassan, Ahmed H S ^a   Stein, Christoph ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Cytokine; Neuro immune interaction; Neuropeptide; Nociception; Opioid

Indexed keywords

CORTICOTROPIN DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NALOXONE; RECOMBINANT INTERLEUKIN 1BETA;

ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HINDLIMB; INTRADERMAL DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPH NODE; MALE; MUSCULOSKELETAL SYSTEM INFLAMMATION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SPLEEN;

EID: 0030581490     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00440-2     Document Type: Article

References (36)

1. Antonijevic, I., S.A. Mousa, M. Schäfer and C. Stein, 1995, Perineurial defect and peripheral opioid analgesia in inflammation, J. Neurosci. 15, 165.
2. Chai, S.Y., E. Tarjan, M.J. McKinley, G. Paxinos and F.A.O. Mendelsohn, 1990, Corticotropin-releasing factor receptors in the rabbit brain visualized by in vitro autoradiography, Brain. Res. 512, 60.
3. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J.G. Giri, S.K. Dower, J.E. Sims and A. Mantovani, 1993, Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4, Science 261, 472.
4. Crofford, L.J., H. Sano, K. Karalis, E.L. Webster, E.A. Goldmuntz, G.P. Chrousos and R.L. Wilder, 1992, Local secretion of corticotropin-releasing hormone in the joints of lewis rats with inflammatory arthritis, J. Clin. Invest. 90, 2555.
5. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat, Br. J. Pharmacol. 113, 63.
6. Deyerle, K.L., J.E. Sims, S.K. Dower and M.A. Bothwell, 1992, Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes, J. Immunol. 149, 1657.
7. Dinarello, C.A., 1994, The interleukin-1 family: 10 years of discovery, FASEB J. 8, 1314.
8. Ferreira, S.H., B.B. Lorenzetti, A.F, Bristow and S. Poole, 1988, Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue, Nature 334, 698.
9. Fukuoka, H., M. Kawatani, T. Hisamitsu and C. Takeshige, 1994, Cutaneous hyperalgesia induced by peripheral injection of interleukin1β in the rat, Brain Res. 657, 133.
10. Hargreaves, K.M., R. Dubner and A.H. Costello, 1989, Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception, Eur. J. Pharmacol. 170, 275.
11. Hassan, A.H.S., A. Ableitner, C. Stein and A. Herz, 1993, Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue, Neuroscience 55, 185.
12. Heijnen C.J., A. Kavelaars and R.E. Ballieux, 1991, β-Endorphin: cytokine and neuropeptide, Immunol. Rev. 119, 41.
13. Hoshi, H., K. Horie, H. Nagata and M. Sato, 1989, A histological and experimental study on the fate of an increased number of lymph follicles produced in the mouse popliteal lymph node by exogenous antigen stimulation, Arch. Histol. Cytol. 52, 485.
14. Karalis, K., H. Sano, J. Redwine, S. Listwak, R.L. Wilder and G.P. Chrousos, 1991, Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo, Science 254, 421.
15. Kawaguchi, Y., M. Harigai, M. Hara, K. Suzuki, M. Kawakami, T. Ishizuka, T. Hidaka, A. Kitani, M. Kawagoe and H. Nakamura, 1992, Increased interleukin-1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis, Biochem. Biophys. Res. Commun. 184, 1504.
16. Lowry, P.J., 1995, The corticotropin-releasing factor-binding protein: from artefact to new ligand(s) and axis, J. Endocrinol. 144, 1.
17. Mackenzie, F.J., J.P. Leonard and M.L. Cuzner, 1989, Changes in lymphocyte β-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat, J. Neuroimmunol. 23, 93.
18. Przewlocki, R., A.H.S. Hassan, W. Lason, C. Epplen, A. Herz and C. Stein, 1992, Gene expression and localization of opioid peptides in immune cells of inflamed tissue. Functional role in antinociception, Neuroscience 48, 491.
19. Schäfer, M., L. Carter and C. Stein, 1994, Interleukin-1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue, Proc. Natl. Acad. Sci. USA 91, 4219.
20. Schäfer, M., S.A. Mousa, Q. Zhang, L. Carter and C. Stein, 1996, Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia, Proc. Natl. Acad. Sci. USA 93, 6096.
21. Sharp, B. and K. Linner, 1993, Editorial: What do we know about the expression of proopiomelanocortin transcripts and related peptides in lymphoid tissue? Endocrinology 133, 1921.
22. Sibinga, N.E.S. and A. Goldstein, 1988, Opioid peptides and opioid receptors in cells of the immune system, Annu. Rev. Immunol. 6, 219.
23. Sims, J.E., M.A. Gayle, J.L. Slack, M.R. Alderson, T.A. Bird, J.G. Giri, F. Colotta, F. Re, A. Mantovani, K. Shanebeck, K.H. Grabstein and S.K. Dower, 1993, Interleukin 1 signaling occurs exclusively via the type I receptor, Proc. Natl. Acad. Sci. USA 90, 6155.
24. 125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease, Immunol. Lett. 18, 5.
25. Smith, E.M., A.C. Morril, W.J. Meyer and J.E. Blalock, 1986, Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins, Nature 321, 881.
26. Stein C., 1995, Mechanisms of disease. The control of pain in peripheral tissue by opioids, N. Engl. J. Med. 332, 1685.
27. Stein, C., A.H.S. Hassan, R. Przewlocki, C. Gramsch, K. Peter and A. Herz, 1990, Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation, Proc. Natl. Acad. Sci. USA 87, 5935.
28. Stein, C., A.H.S. Hassan, K. Lehrberger, J. Giefing and A. Yassouridis, 1993, Local analgesic effect of endogenous opioid peptides, Lancet 342, 321.
29. Stünkel, K.G., P. Theisen, A. Mouzaki, T. Diamantstein, and H.D. Schlumberger, 1988, Monitoring of interleukin-2 receptor (IL-2R) expression in vivo and studies on an IL-2R-directed immunosuppressive therapy of active and adoptive adjuvant-induced arthritis in rats, Immunol. 64, 683.
30. Takao, T., W.M. Mitchell and E.B. De Souza, 1991, Interleukin-1 receptors in mouse kidney; identification, localization, and modulation by lipopolysaccharide treatment, Endocrinology 128, 2618.
31. 125I]interleukin-1 binding in brain, endocrine and immune tissues, Brain Res. 623, 172.
32. Uhl, J., R.C. Newton, J.G. Giri, G. Sandlin and R. Horuk, 1989, Identification of IL-1 receptors of human monocytes, J. Immunol. 142, 1576.
33. Webster, E.L. and E.B. De Souza, 1988, Corticotropin-releasing factor receptors in mouse spleen: identification autoradiographic localization, and regulation by divalent cations and guanine nucleotides, Endocrinology 122, 609.
34. Webster, E.L., D.E. Tracey, M.A. Jutila, S.A. Wolfe and E.B. De Souza, 1990, Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages, Endocrinology 127, 440.
35. Wei, E.T. and H.A. Thomas, 1993, Anti-inflammatory peptide agonists, Annu. Rev. Pharmacol. Toxicol. 33, 91.
36. Wiedermann, C.J., P. Sacerdote, E. Mur, U. Kinigadner, T. Wicker, A.E. Panerai and H. Braunsteiner, 1992, Decreased immunoreactive β-endorphin in mononuclear leucocytes from patients with rheumatic diseases, Clin. Exp. Immunol. 87, 178.